GNI Group Ltd
GNI Group Ltd. engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally. The company offers Etuary for the treatment of idiopathic pulmonary fibrosis. It is also developing Etuary, which is in Phase III clinical trial for the treatment of connective tissue-associated interstitial lung disease; and in clinical trial pre-phase III clinical tri… Read more
GNI Group Ltd (3G6) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2024: -0.028x
Based on the latest financial reports, GNI Group Ltd (3G6) has a cash flow conversion efficiency ratio of -0.028x as of June 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.12 Billion) by net assets (€39.56 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
GNI Group Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how GNI Group Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
GNI Group Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of GNI Group Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Parksystems Corp
KQ:140860
|
0.014x |
|
Korian S.A.
LSE:0OPS
|
0.063x |
|
Ennoconn Corp
TW:6414
|
0.067x |
|
Cleanaway Co Ltd
TW:8422
|
0.142x |
|
Firstsource Solutions Limited
NSE:FSL
|
0.102x |
|
Wuxi Huadong Heavy Machinery Co Ltd
SHE:002685
|
0.044x |
|
Capitol Federal Financial Inc
NASDAQ:CFFN
|
0.017x |
|
TRTPF
PINK:TRTPF
|
N/A |
Annual Cash Flow Conversion Efficiency for GNI Group Ltd (2013–2024)
The table below shows the annual cash flow conversion efficiency of GNI Group Ltd from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €39.71 Billion | €-3.16 Billion | -0.080x | -157.46% |
| 2023-12-31 | €36.05 Billion | €5.00 Billion | 0.139x | +599.00% |
| 2022-12-31 | €19.81 Billion | €393.00 Million | 0.020x | -30.76% |
| 2021-12-31 | €19.27 Billion | €552.00 Million | 0.029x | -73.43% |
| 2020-12-31 | €12.77 Billion | €1.38 Billion | 0.108x | +79.22% |
| 2019-12-31 | €13.10 Billion | €788.00 Million | 0.060x | +32.93% |
| 2018-12-31 | €13.72 Billion | €621.00 Million | 0.045x | +228.20% |
| 2017-12-31 | €13.48 Billion | €-476.00 Million | -0.035x | +69.10% |
| 2016-12-31 | €4.53 Billion | €-518.00 Million | -0.114x | -53.37% |
| 2015-12-31 | €5.13 Billion | €-382.00 Million | -0.075x | +23.99% |
| 2014-12-31 | €5.78 Billion | €-567.00 Million | -0.098x | +41.18% |
| 2013-12-31 | €3.97 Billion | €-662.00 Million | -0.167x | -- |